THE ROLE OF CYTOKINE NETWORK IN HEPATOCELLULAR DAMAGE CAUSED BY СHRONIC HEPATITIS C

THE ROLE OF CYTOKINE NETWORK IN HEPATOCELLULAR DAMAGE CAUSED BY СHRONIC HEPATITIS C

Abstract. Hepatitis C virus (HCV) is the leading cause of chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. Liver damage in chronic viral hepatitis C is caused by both direct cytopathic viral effects, and indirect immune-mediated mechanisms. The cytokines locally produced in the liver...

Full description

Saved in:

Bibliographic Details
Main Author:	L. Ph. Skljar
Format:	Article
Language:	Russian
Published:	St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2014-07-01
Series:	Медицинская иммунология
Subjects:	chronic viral hepatitis c cytokines fibrosis
Online Access:	https://www.mimmun.ru/mimmun/article/view/441
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

APOPTOSIS SYSTEM AND ITS RELATIONS TO HEPATOCELLULAR DAMAGE AND SOME INDEXES OF LOCAL CYTOKINE PROFILE CHRONIC HCV INFECTION
by: L. Ph. Skljar, et al.
Published: (2014-07-01)

Bacterial overgrowth syndrome in adolescents with Сhronic viral hepatitis C
by: N. D. Venclovaite, et al.
Published: (2021-04-01)

Сhronic hepatitis C in patients with мetabolic syndrome
by: T. V. Antonova, et al.
Published: (2014-09-01)

Morphogenesis of pericellular liver fibrosis in patients with chronic viral hepatitis C associated with hepatic steatosis
by: V. A. Tumanskiy, et al.
Published: (2012-08-01)

The significance of the detoxification system disorders in fibrogenesis in Chronic Viral Hepatitis С in children
by: E. A. Galova, et al.
Published: (2021-07-01)

Сomparative morphological characteristics of activity score and fibrosis stage in chronic viral hepatitis C
by: I. L. Purlik, et al.
Published: (2010-10-01)

Diagnostic values of MMP-9 and TGF-1β in assessing the severity of liver fibrosis and the rate of its progression in patients with chronic hepatitis C GT 1 infection
by: H. V. Venytska, et al.
Published: (2023-07-01)

Development of approaches to the evaluation of pharmacotherapy effectiveness for chronic hepatitis C
by: I. A. Narkevich, et al.
Published: (2024-02-01)

Clinical and epidemiological characteristic of chronic hepatitis C in the republic of Tyva
by: A. A. Saryglar, et al.
Published: (2023-04-01)

Assessment of pro-inflammatory cytokines in sera of patients with hepatitis C virus infection before and after anti-viral therapy
by: Abdulkarim Alhetheel, et al.
Published: (2016-10-01)

Сontent of interferon-γ and interleukin-4 in blood serum of patients with chronic hepatitis С with mixed crioglobulinemia
by: O. P. Mashko, et al.
Published: (2012-04-01)

The evaluation of liver fibrosis regression in chronic hepatitis C patients after the treatment with direct-acting antiviral agents – A review of the literature
by: Olga H. Orasan, et al.
Published: (2019-10-01)

Change of the indices of the cytokine status in patients with chronic combined hepatitis B+C in a process of antiviral therapy
by: O. L. Sobolevskaya
Published: (2014-09-01)

Effectiveness of combined antyviral therapy in children with chronic hepatitis C
by: G. P. Martynova, et al.
Published: (2014-09-01)

Clinical-epidemiological and pathogenetic features of viral hepatitis C in the hemodialysis departments
by: R. N. Akalaev, et al.
Published: (2019-12-01)

THE SIGNIFICANCE OF QUANTITIES DETECTION OF СORE ANTIGEN IN BLOOD SERUM OF CHILDREN WITH HEPATITIS C
by: A. Leybman, et al.
Published: (2015-08-01)

Determination of correlation between cytokines IL 6, IL8, IL10, IL12, IL17 and severity of hepatocellular carcinoma in patients having hepatitis C
by: Ishtiaq Ahmad, et al.
Published: (2024-11-01)

DYNAMICS OF INTRACELLULAR HOMEOSTASIS PARAMETERS IN PATIENTS WITH CHRONIC VIRUS HEPATITIS C
by: S.M. Gramatyuk
Published: (2017-11-01)

Prognostic model of rapid hepatic fibrosis progression in men with chronic hepatitis C
by: T. I. Koval, et al.
Published: (2019-05-01)

Clinical features of chronic hepatitis C in children
by: M. S. Bokhonov, et al.
Published: (2023-06-01)

CYTOKINE RESPONSE ASSOCIATED WITH HEPATITIS C VIRUS CLEARANCE IN HIV COINFECTED PATIENTS INITIATING PEG INTERFERON- BASED THERAPY.
by: Truong Tam Nguyen, et al.
Published: (2016-01-01)

Clinical and laboratory characteristics of chronic hepatitis C on the early stages of development
by: N. S. Zhevnerova, et al.
Published: (2016-12-01)

Liver injury under chronic viral hepatitis C against the background of opiomania: morphological characters
by: Ye. V. Beloborodova, et al.
Published: (2011-02-01)

Comorbidity and multimorbidity in patients with chronic hepatitis C
by: Ya. E. Saranskaya, et al.
Published: (2022-10-01)

IMPACT OF ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS C ON CYTOKINE SYNTHESIS AND HEPATIC FIBROSING PROCESSES
by: V. V. Shchekotov, et al.
Published: (2015-08-01)

Viral hepatitis B and C: similarities and difference
by: M. S. Karyagina, et al.
Published: (2021-06-01)

TLR7 gene effect on hepatic fibrosis progression rate in HIV-infected patients with chronic hepatitis C
by: L. M. Syzova, et al.
Published: (2019-06-01)

Bridging viral hepatitis and liver cancer: Emerging concepts in pathogenesis and therapeutic innovation
by: Keyin Zheng, et al.
Published: (2025-06-01)

The importance of single-nucleotide gene polymorphisms in the formation of liver cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C
by: I. V. Mannanova, et al.
Published: (2024-06-01)

IMMUNOLOGICAL FEATURES IN LIVER CIRRHOSIS INDUCED BY HEPATITIS B VIRUS
by: O. I. Urazova, et al.
Published: (2014-07-01)

Serum Elabela Level as a Reliable Biomarker for Predicting of Liver Fibrosis in Iraqi Patients with Chronic Hepatitis C
by: Eham Amer Ali, et al.
Published: (2024-07-01)

Application of dicarbamin in treatment of patients by a chronic hepatitis C
by: D. Yu. Konstantinov, et al.
Published: (2011-09-01)

Clinical and immunomorphological predictors of the adverse course of chronic hepatitis C
by: I. A. Karabak, et al.
Published: (2020-06-01)

lncRNAs as Biomarkers of Hepatocellular Carcinoma Risk and Liver Damage in Advanced Chronic Hepatitis C
by: Driéle B. dos Santos, et al.
Published: (2025-05-01)

Dynamics of Interferon-G and Interleukine-4 levels in serum of patients with chronic hepatitis C with mixed cryoglobulinemia on the background of immunomodulatory therapy
by: O. P. Mashko, et al.
Published: (2012-12-01)

Relationships between HBeAg status of patients with chronic hepatitis B and changes in serum TNF-α, viral load and severity of morphological changes in the liver according to non-invasive tests
by: A. B. Khelemendyk, et al.
Published: (2021-05-01)

Economic burden of chronic viral hepatitis C
by: R. A. Yakhina, et al.
Published: (2022-01-01)

Genetic polymorphism of hepatitis C virus and risk of hepatocellular carcinoma
by: S. N. Mammayev, et al.
Published: (2014-09-01)

Lipid and carbohydrate metabolism disturbances in children with chronic hepatitis C
by: A. O. Nikiforova, et al.
Published: (2024-09-01)

Epidemiology of hepatitis B and C among risk groups in Czechia
by: Iva Bendlova, et al.
Published: (2025-05-01)